PD-L1 photoimmunotherapy kills immunosuppressive myeloid cells to activate local and systemic antitumor immunity

被引:0
|
作者
Thorne, H. [1 ]
Lapetoda, Jason [1 ]
Ma, Gina [1 ]
Gordon, Myra [1 ]
Osada, Takuya [1 ]
Suzuki, Toshiaki [1 ]
机构
[1] Rakuten Med, San Diego, CA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
E-2016
引用
收藏
页码:662 / 662
页数:1
相关论文
共 50 条
  • [1] PD-L1 photoimmunotherapy kills immunosuppressive myeloid cells to activate local and systemic antitumor immunity in syngeneic mouse models.
    Thorne, Amy H.
    Hsu, Michelle H.
    Mendoza, Daniel
    Lapetoda, Jason
    Parry, Christopher M.
    Fong, Jerry J.
    Garcia-Guzman, Miguel
    CANCER RESEARCH, 2021, 81 (13)
  • [2] Function of PD-L1 in antitumor immunity of glioma cells
    Lou Yongli
    Shi Jin
    Guo Dewei
    Qureshi, Ahmad Kaleem
    Song Laijun
    SAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2017, 24 (04) : 803 - 807
  • [3] Black phosphorus nanosheets activate tumor immunity of glioblastoma by modulating the expression of the immunosuppressive molecule PD-L1
    Xiong, Yue
    He, Chao
    Qi, Junyang
    Xiong, Meimei
    Liu, Shuna
    Zhao, Jingxin
    Li, Yuzhen
    Liu, Gan
    Deng, Wenbin
    BIOMATERIALS, 2025, 317
  • [5] An NK cell line (PD-L1 t-haNK) engineered to target PD-L1 efficiently kills tumor cells and myeloid derived suppressor cells
    Fabian, Kellsye
    Padget, Michelle
    Donahue, Renee
    Solocinski, Kristen
    Allen, Clint
    Lee, John
    Soon-Shiong, Patrick
    Schlom, Jeffrey
    Hodge, James
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [6] PD-L1 in Systemic Immunity: Unraveling Its Contribution to PD-1/PD-L1 Blockade Immunotherapy
    Bocanegra, Ana
    Blanco, Ester
    Fernandez-Hinojal, Gonzalo
    Arasanz, Hugo
    Chocarro, Luisa
    Zuazo, Miren
    Morente, Pilar
    Vera, Ruth
    Escors, David
    Kochan, Grazyna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (16) : 1 - 17
  • [7] The complex role of PD-L1 in antitumor immunity: a recent update
    Xiaoqing Zhang
    Yue Huang
    Xuanming Yang
    Cellular & Molecular Immunology, 2021, 18 : 2067 - 2068
  • [8] Pomalidomide Inhibits PD-L1 Induction to Promote Antitumor Immunity
    Fujiwara, Yuki
    Sun, Yi
    Torphy, Robert J.
    He, Jiadai
    Yanaga, Katsuhiko
    Edil, Barish H.
    Schulick, Richard D.
    Zhu, Yuwen
    CANCER RESEARCH, 2018, 78 (23) : 6655 - 6665
  • [9] Spatiotemporal depletion of tumor-associated immune checkpoint PD-L1 with near-infrared photoimmunotherapy promotes antitumor immunity
    Taki, Shunichi
    Matsuoka, Kohei
    Nishinaga, Yuko
    Takahashi, Kazuomi
    Yasui, Hirotoshi
    Koike, Chiaki
    Shimizu, Misae
    Sato, Mitsuo
    Sato, Kazuhide
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (11)
  • [10] Conditional PD-1/PD-L1 Probody Therapeutics Induce Comparable Antitumor Immunity but Reduced Systemic Toxicity Compared with Traditional Anti-PD-1/PD-L1 Agents
    Assi, Hikmat H.
    Wong, Chihunt
    Tipton, Kimberly A.
    Mei, Li
    Wong, Ken
    Razo, Jennifer
    Chan, Chanty
    Howng, Bruce
    Sagert, Jason
    Krimm, Michael
    Diep, Linnea
    Jang, Andrew
    Nguyen, Margaret T.
    Lapuyade, Nicole
    Singson, Victoria
    Villanueva, Ruth
    Paidhungat, Madan
    Liu, Shouchun
    Rangan, Vangipuram
    Vasiljeva, Olga
    West, James W.
    Richardson, Jennifer H.
    Irving, Bryan
    Daniel, Dylan
    Belvin, Marcia
    Kavanaugh, W. Michael
    CANCER IMMUNOLOGY RESEARCH, 2021, 9 (12) : 1451 - 1464